Patient preparation for diagnostic nuclear medicine imaging procedures: an analysis of ward nurse knowledge

Radiography ◽  
2002 ◽  
Vol 8 (3) ◽  
pp. 139-147 ◽  
Author(s):  
R. Higgins ◽  
P. Hogg
Keyword(s):  
Nuclear Medicine ◽  
Imaging Procedures ◽  
Nuclear Medicine Imaging ◽  
Diagnostic Nuclear Medicine ◽  
Ward Nurse ◽  
Patient Preparation ◽  
Nurse Knowledge

Computers in Diagnostic Nuclear Medicine Imaging - A Review

1989 ◽  
Vol 39 (3) ◽  
pp. 319-328
Author(s):  
K. K. Kapoor ◽  
R. Prakash ◽  
S. Khushu ◽  
R. V. Narayanan
Keyword(s):  
Nuclear Medicine ◽  
Nuclear Medicine Imaging ◽  
Diagnostic Nuclear Medicine

scholarly journals An overview of nuclear medicine imaging procedures

2015 ◽  
Vol 30 (13) ◽  
pp. 52-60
Author(s):  
Peter Hogg ◽  
Richard Lawson
Keyword(s):  
Nuclear Medicine ◽  
Imaging Procedures ◽  
Nuclear Medicine Imaging

Nuclear Medicine Imaging Procedures in Oncology

2021 ◽  
pp. 297-323
Author(s):  
Ajay-Mohan Mohan ◽  
Nicola Beindorff ◽  
Winfried Brenner
Keyword(s):  
Nuclear Medicine ◽  
Imaging Procedures ◽  
Nuclear Medicine Imaging

Three-dimensional coded-aperture techniques in diagnostic nuclear medicine imaging

1998 ◽  
Author(s):  
Li Zhang ◽  
Richard C. Lanza ◽  
Berthold K. P. Horn ◽  
Robert E. Zimmerman
Keyword(s):  
Nuclear Medicine ◽  
Three Dimensional ◽  
Coded Aperture ◽  
Nuclear Medicine Imaging ◽  
Diagnostic Nuclear Medicine

Patient Exposure and Radiation Risk in Bulgarian Diagnostic Nuclear Medicine I. Survey of Diagnostic Nuclear Medicine Procedures in Bulgaria in 1980

1982 ◽  
Vol 21 (03) ◽  
pp. 85-91 ◽  
Author(s):  
R. Poppitz
Keyword(s):  
Nuclear Medicine ◽  
Radiation Risk ◽  
Patient Exposure ◽  
Diagnostic Nuclear Medicine ◽  
Nuklearmedizinische Diagnostik ◽  
Nuclear Medicine Procedures

Um die Strahlenexposition und das Strahlenrisiko für die Bevölkerung durch die nuklearmedizinische Diagnostik in Bulgarien zu ermitteln, wurde eine Erhebung für das Jahr 1980 über die Arten und Anzahl der Applikationen von Radiopharmaka, über die verwendeten Aktivitäten und über die Geschlechts- und Altersverteilung der untersuchten Patienten durchgeführt. Die Gesamtzahl diagnostischer in vivo Applikationen betrug 116418 (davon 40,5% bei Männern und 59,5% bei Frauen), d.h. 13,1 Applikationen per 1000 Einwohner. Die applizierte Gesamtaktivität aller 44 verwendeter Radiopharmaka betrug ca. 2,1 TBq (56 Ci). Die Geschlechts- und Altersverteilung der untersuchten Patienten war ähnlich jener in anderen Ländern: nur 17,4% aller Patienten waren im reproduktionsfähigen Alter, 52,7% waren über 45 Jahre alt. Im Vergleich zu anderen entwickelten Ländern war in Bulgarien im Jahr 1980 der Anteil der 131J-Jodid-Untersuchungen verhältnismäßig hoch.

Patients with fever of unknown origin (FUO): diagnosis by nuclear medicine imaging

2001 ◽  
Vol 40 (03) ◽  
pp. 59-70 ◽  
Author(s):  
W. Becker ◽  
J. Meiler
Keyword(s):  
Nuclear Medicine ◽  
Fever Of Unknown Origin ◽  
Tumor Imaging ◽  
White Blood Cells ◽  
Unknown Origin ◽  
Final Diagnosis ◽  
Recurrent Fever ◽  
Nuclear Medicine Imaging

SummaryFever of unknown origin (FUO) in immunocompetent and non neutropenic patients is defined as recurrent fever of 38,3° C or greater, lasting 2-3 weeks or longer, and undiagnosed after 1 week of appropriate evaluation. The underlying diseases of FUO are numerous and infection accounts for only 20-40% of them. The majority of FUO-patients have autoimmunity and collagen vascular disease and neoplasm, which are responsible for about 50-60% of all cases. In this respect FOU in its classical definition is clearly separated from postoperative and neutropenic fever where inflammation and infection are more common. Although methods that use in-vitro or in-vivo labeled white blood cells (WBCs) have a high diagnostic accuracy in the detection and exclusion of granulocytic pathology, they are only of limited value in FUO-patients in establishing the final diagnosis due to the low prevalence of purulent processes in this collective. WBCs are more suited in evaluation of the focus in occult sepsis. Ga-67 citrate is the only commercially available gamma emitter which images acute, chronic, granulomatous and autoimmune inflammation and also various malignant diseases. Therefore Ga-67 citrate is currently considered to be the tracer of choice in the diagnostic work-up of FUO. The number of Ga-67-scans contributing to the final diagnosis was found to be higher outside Germany than it has been reported for labeled WBCs. F-l 8-2’-deoxy-2-fluoro-D-glucose (FDG) has been used extensively for tumor imaging with PET. Inflammatory processes accumulate the tracer by similar mechanisms. First results of FDG imaging demonstrated, that FDG may be superior to other nuclear medicine imaging modalities which may be explained by the preferable tracer kinetics of the small F-l 8-FDG molecule and by a better spatial resolution of coincidence imaging in comparison to a conventional gamma camera.

Sign in / Sign up

Export Citation Format

Share Document